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laparoscopic surgical staging consisting in total laparoscopic hysterec-
tomy, bilateral salpingo-oophorectomy and pelvic lymphadenectomy.
Pneumoperitoneum was created using a Veress needle placed at
supraumbilical level with a maximum intra-abdominal pressure of
12 mm Hg. Four laparoscopic ports were created: two 10 mm ports
(one midline supraumbilical for the optical and one ancillary lateral
left), and two ancillary 5 mm ports (one lateral right and one supra-
pubic). Ancillary ports were used for peritoneal washing, coagulation
of fallopian tubes, coagulation and cut of round ligaments, division of
the broad ligament leafs, pelvic nodes dissection, coagulation and cutBackground
Port-site metastases were described after laparoscopic surgery for
non-gynecological and gynecological cancers. In one of the largest pub-
lished series (Zivanovic et al., 2008) the incidence of port-site metastases
was 1.18%, i.e. 20 cases after 1694 laparoscopic procedures performed,
and the 95% of cases had simultaneous carcinomatosis or metastases to
other sites at the time of port-site metastasis detection suggesting that
the presence of port-site implantation is a surrogate for advanced disease.
During the last years there was a growing interest in port-site recur-
rence after laparoscopic treatment of gynecological cancers probably
due to the increasing use of the laparoscopy in gynecologic oncology,
specially for staging early stage endometrial cancers. At the moment,
only three cases of isolated port-site metastasis after endometrial can-
cer have been reported in literature (Martínez et al., 2010).
Here we reported the fourth case of isolated port-site metastasis
after laparoscopic stadiation for an early stage endometrial cancer.
Case
In April 2009, a 66 years-old normal-weight (body mass index
24.2 kg/m2) woman referring postmenopausal uterine bleeding
underwent an ofﬁce hysteroscopy with endometrial biopsy. Histolo-
gy revealed a grade 2 endometrioid adenocarcinoma. After clinical
and imaging evaluation showing a disease conﬁned to uterus andics & Gynecology, University
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fof infundibolo-pelvic ligaments. Nodes were removed through vagi-
nal route using an endobag.
During coagulation of second (right) uterine pedicle, the uterus
was perforated with the uterine manipulator. After promptly uterine
suturing, the surgery was converted to laparoscopically-assisted vag-
inal hysterectomy. Thus, colpotomy, ﬁnal ligation and section of uter-
ine pedicles and of cardinal-uterosacral complex, extraction of uterus
and adnexa, and vaginal cuff suture were performed vaginally. The
ports were all closed with skin stitches, only for 10 mm ports the fas-
cia was also sutured. Abdomen was deﬂated with trocars in place and
a 5% polyvidone iodine was instillated before closing all ports.
The histologic examination conﬁrmed a grade 2 endometrioid ad-
enocarcinoma conﬁned to uterus and showed an invasion of 70% o
themyometrium, lymphovascular space involvement, nodes and peri-
toneal cytology were not involved. Final staging was FIGO stage IB.
In consideration of the presence of two adverse events, i.e. advanced
age (>60 years) and lymphovascular space involvement, three cycles o
external beam radiotherapy (EBR, total dose of 46 Gy; 2 Gy/day frac-
tions for 5 days/week) and vaginal brachytherapy (VB, total dose o
22 Gy; 5.5 Gy; fractions twiceweekly for twoweeks)were administrat-
ed. Speciﬁcally, the target volume of the EBR consisted of the pelvic re-
gion (from the proximal two-third of the vagina up to the promontory)
whereas that of the VB was the entire vaginal wall (from the proxima
vaginal cuff to within 1–2 cm of the urethral meatus) with a depth o
5 mm from the vaginal stump applicator surface.
Patient's follow-up was performed according to internal multidis-
ciplinary guidelines.
On March 2011, the patient showed a symptomatic and palpable
abdominal wall mass of about 2 cm diameters under the left port-
site at the level of the left iliac fossa. Magnetic resonance imaging
conﬁrmed the presence of a parietal recurrence in the subcutaneous
tissue without involvement of the underlying fascia and any other
Fig. 1. A. Macroscopic appearance of the port-site metastasis. B. Histological view of the port-site metastasis. i. Hematoxylin and eosin stain (magniﬁcation: ×50). ii. Cytokeratin 7
positive immunostaining (magniﬁcation: ×200).
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tomography (FDG-PET) reported a localized FDG uptake.
Surgical excision of the lesion, including skin and subcutaneous
tissue reaching the muscular fascia was performed. At the same
time, the patient underwent a diagnostic laparoscopy. Pneumoperito-
neum was again created using a Veress needle at supraumbilical level
using a low intra-abdominal pressure (12 mm Hg) and 3 laparoscopic
ports were created using the same accesses previously used (one
10 mm midline supraumbilical for the optical and two 5 mm ancil-
lary, one lateral right and one suprapubic). During procedure, careful
intra-abdominal inspection, peritoneal washing, wide left peritonect-
omy under the port site, and random biopsies were performed. No
macroscopic evidence of tumor recurrence or ascites was detected.
Macroscopically removed mass measured 6×4.5×3.5 cm and in-
cluded a lardaceous nodule of 2.2 cm major axis (Fig. 1A). Pathologic
examination revealed a metastasis of poorly differenced adenocarci-
noma with positive immunostaining for estrogens’ receptors
(Fig. 1Bi), cytokeratin 7 (Fig. 1Bii), and negative staining for cytoker-
atin 20 and vimentin, conﬁrming the endometrial origin of tumor.
Peritoneum, random biopsies and peritoneal washing were negative.
After surgery the patient was treated with tumor directed radio-
therapy and chemotherapy (cysplatin/doxorubicin/paclitaxel) due
to poor histologic differentiation of tumor. To date, the patient is
alive and free of disease.
Discussion
We report a very rare case of isolated port-sitemetastasis after lap-
aroscopic surgery for early stage endometrial cancer. The current was
the ﬁrst case of port-site metastasis after 451 consecutive patientslaparoscopically operated in our Institution for early stage endometri-
al cancer. The incidence of 0.2% was very low and in agreement with
previous data (Zivanovic et al., 2008; Martínez et al., 2010).
The current case highlights, ﬁrstly, the unsolved mystery of the
development of isolated metastasis even at port-site after uterine
perforation, even if the trocar was left in place during abdomen de-
ﬂation and instillation with polyvidone iodine solution before port
closing (Ramirez et al., 2003), and, secondly, the need of more ag-
gressive strategies, although of unproven efﬁcacy, in case of poten-
tially increased risk for port-site metastasis, as the inclusion of the
laparoscopic ports in the radiotherapy ﬁelds that in our case were
left out.
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